School of Medicine


Showing 1-100 of 167 Results

  • Elias Aboujaoude, MD, MA

    Elias Aboujaoude, MD, MA

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Aboujaoude is a Clinical Professor, researcher and writer at Stanford University's Department of Psychiatry, where he is Chief of the Anxiety Disorders Section and Director of the OCD Clinic and the Impulse Control Disorders Clinic. Besides the compulsivity-impulsivity spectrum, his work has focused on the intersection of technology and psychology, with an emphasis on the problematic use of Internet-related technologies, mental health in a post-privacy world, and the potential for telemedicine interventions such as virtual reality and video-based therapy to increase access to care and advance global health. His books include "Virtually You: The Dangerous Powers of the e-Personality" and "Mental Heath in the Digital Age: Grave Dangers, Great Promise". Dr. Aboujaoude also teaches psychology on the main Stanford campus and at UC Berkeley. Scholarly and media platforms that have featured his work include The New York Times, The Wall Street Journal, The Washington Post, Congressional Quarterly, The Harvard Business Review, The Chronicle of Higher Education, BBC, PBS, and CNN.

  • Sarah Adler

    Sarah Adler

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests I am interested in the design and delivery of clinical care using, data and technology. I have focused on disordered eating behaviors and obesity.

  • W. Stewart Agras

    W. Stewart Agras

    Professor of Psychiatry and Behavioral Sciences, Emeritus

    Current Research and Scholarly Interests My research is focused on disorders of human feeding including the eating disorders: anorexia nervosa, bulimia nervosa, and binge eating disorder. Ongoing or recently completed studies include: A controlled trial of the implementation of interpersonal psychotherapy for eating disorders and depression on college campuses across the U.S. A multisite controlled study of two types of family therapy for the treatment of adolescent anorexia nervosa. Early prevemtion of overweight and obesity.

  • Raag Airan

    Raag Airan

    Assistant Professor of Radiology (Neuroimaging) and, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Our goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.

  • Amy Alexander

    Amy Alexander

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests College Mental Health, Emotional Support Animals & Service Animals, Women's Health, Mental Health & Well-being in Veterinarians

  • Bruce Arnow, Ph.D.

    Bruce Arnow, Ph.D.

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult) at the Stanford University Medical Center

    Current Research and Scholarly Interests Current research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.

  • Sepideh Bajestan, MD, PhD

    Sepideh Bajestan, MD, PhD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Neuropsychiatry
    Functional Neurological Symptom Disorders, Psychogenic Non-Epileptic Seizures
    Group and Individual Psychotherapy
    Impulse Control Disorders

  • Tali Ball, PhD

    Tali Ball, PhD

    Instructor, Psychiatry and Behavioral Sciences

    Bio Tali Ball, PhD is the Director of the Stanford Translational Anxiety Research (STAR) Lab and an Instructor in the Stanford Department of Psychiatry and Behavioral Sciences. Her primary research aim is to translate neurobiologically-based models of anxiety into improved treatment outcomes. She received her PhD in Clinical Psychology from the SDSU/UCSD Joint Doctoral Program, where her dissertation work established relationships between brain activation during fear extinction learning and anxiety reduction following a brief exposure intervention. Her postdoctoral research focused on developing clinically useful metrics of brain circuit function and incorporating neuroscience-based assessments into clinical practice. Her work brings together clinical psychology, neuroscience, and computational approaches, always with an eye towards how the results of the science can be directly implemented in clinical practice.

  • Jacob S. Ballon

    Jacob S. Ballon

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Jacob S. Ballon, M.D., M.P.H. specializes in the treatment of people with psychotic disorders including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford which provides interdisciplinary care for people experiencing psychosis. He is also the medical director of H2 acute inpatient unit and the co-director of the specialty psychiatry clinics section in the Department of Psychiatry. Dr. Ballon completed his residency at Stanford in 2009 and a Schizophrenia Research Fellowship at Columbia University in 2011.

    INSPIRE is an innovative interdisciplinary client-centered resource providing respectful evidence-based care to support people to achieve meaningful recovery from psychosis through collaborative partnership with individuals and their families while advancing knowledge and training for a new generation of providers. With a recovery-oriented philosophy, the clinic provides an array of services including psychopharmacology, psychotherapy, and psychosocial evaluations. As a research clinic, they are focused on collaborating with multiple disciplines throughout the university to conduct clinical and basic science research including functional imaging, clinical trials, basic pathophysiology, and genetics.

    Dr. Ballon maintains an interest in understanding the connections between the brain and the rest of the body as relates to the manifestation and treatment of people who experience psychosis. He co-chairs a diverse working group that brings together researchers from throughout the university and technology community to investigate these connections and look at innovative ways to combine large-scale data to elucidate new strategies for developing pathways to prevention or treatment of psychosis. He has active projects investigating the metabolic implications of schizophrenia and of psychiatric medication including the association of antipsychotic medication with weight gain and insulin resistance.

    In understanding the whole-body impact of psychiatric illness, Dr. Ballon also has an active interest in the role that exercise can play in psychiatric treatment. He co-chairs Brain-Ex, a multidisciplinary research partnership of clinical research, neuroscience, exercise physiology, and prevention medicine to build the capacity to study the impact of physical exercise on brain response, reward pathways, neuroprotection, and prevention of psychiatric disorders. This program aims to study the neurobiology of elite athletic performance, sustained exercise behavior, and the subjective experience of exercise, as well as the potential for exercise to prevent and reverse neurodegenerative psychiatric disorders. He is the site-principal investigator of an NIMH-funded clinical trial looking at the use of aerobic exercise to improve cognition in people with schizophrenia.

  • Belinda Bandstra

    Belinda Bandstra

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Belinda S. Bandstra, MD, MA, is Clinical Associate Professor, Assistant Director of Residency Training, and Chief of the General Resident Continuity Clinic in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She supervises residents in the General Clinic, Evaluation Clinic, Individual Psychotherapy Clinic and Psychosocial Treatment Clinic, in addition to maintaining a small general clinical practice of her own. Dr. Bandstra has specific interests in issues of culture in psychiatry, transitional age mental health, and mental health and wellness in academia.

    Dr. Bandstra also teaches extensively in the Adult Psychiatry Residency Training Program. She co-directs residency coursework in: Sociocultural Issues in Psychiatry; Leadership, Scholarship, and Career Development; and Essentials of Psychiatry. Dr. Bandstra is a member of the Association for Academic Psychiatry and the American Association of Directors of Psychiatric Residency Training.

  • Nataly Sumarriva Beck

    Nataly Sumarriva Beck

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Dr. Beck's clinical research includes the relationship between catatonia and substance use. In addition, she works on first-episode psychosis, with a focus on treatments in the young adult population.

  • Ori-Michael Johanan Benhamou

    Ori-Michael Johanan Benhamou

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Benhamou received his Bachelor's degree at Duke University and went on to complete medical school at Ben-Gurion University. He completed his residency in Psychiatry at Westchester Medical Center and fellowship in Addiction Medicine at Stanford. He has published works in the areas of suicide, autoimmune encephalitis and addiction. His current interests include substance abuse, the role of transcranial magnetic stimulation on addiction and the intersection of suicide and substance abuse.

  • Brandon S. Bentzley, MD, PhD

    Brandon S. Bentzley, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Bentzley is a psychiatrist and Instructor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.

    His clinical interests include the treatment of substance use disorders and depression using advanced techniques and technologies such as neurostimulation. His research interests include advances in neurostimulation-based treatments, suicide prevention and neuroeconomics.

    As a postdoctoral fellow, Dr. Bentzley was the recipient of a National Institute of Mental Health research training grant. Currently, he is principal investigator on a study funded by the National Institute on Drug Abuse that focuses on understanding the role of dopamine in economic decision making. Further, Dr. Bentzley is co-investigator of a study that received grant support from the American Foundation for Suicide Prevention. This randomized, controlled trial investigates ketamine therapy with a transition to buprenorphine for the treatment of acute suicidality. The study is scheduled for completion in 2022.

    Dr. Bentzley is also a consultant for industry innovators, such as an organization conducting research into new treatments for opioid use disorder and another focusing on data science and psychometrics.

    He has authored articles on surgically implanted neuromodulatory technology for treatment-resistant depression, the origins of selective vulnerability to opioid addiction, the antidepressant effects of ketamine, the role of neurons in cocaine demand, and other topics.

    His work has appeared in the American Journal of Psychiatry, Proceedings of the National Academy of Sciences, Molecular Psychiatry, and elsewhere. In addition, he is a reviewer for the Journal of Substance Abuse Treatment, European Journal of Neuroscience, Behavioural Brain Research, and Addiction Biology.

    Dr. Bentzley has delivered invited lectures including psychiatry grand grounds at Stanford and other medical centers. He has held leadership positions on committees focused on medical education and residency programs, among them Stanford?s Psychiatry Residency Neuroscience Curriculum Committee and the Psychiatry Residency Wellbeing Committee.

    Dr. Bentzley has received honors for his scholarship. He was a member of a team that won the American Psychiatric Association?s ?MindGames? national residency competition, was a Ruth Fox Scholar, as designated by the American Society of Addiction Medicine, and won the Distinguished Graduate of the Year Award from the Medical University of South Carolina.

    He is a member of the American Psychiatric Association, American Society of Addiction Medicine, American Society for Neurosciences, and American Association for the Advancement of Science. Dr. Bentzley has provided community outreach mental health services as a clinical volunteer.

  • Mahendra Bhati

    Mahendra Bhati

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Bhati is a board certified neuropsychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia and was a principle investigator for the DSM-5 academic field trials. His research experience included roles as an investigator in the first controlled clinical trials of deep brain stimulation and low field synchronized TMS for treatment of depression. His current interests include studying TMS-evoked potentials as biomarkers for neuropsychiatric disorders, augmented-reality TMS, closed-loop responsive neurostimulation for treatment of impulse and fear-related disorders, and magnetic resonance guided focused ultrasound for treatment-resistant obsessive compulsive disorder and depression.

  • Kim Bullock, MD

    Kim Bullock, MD

    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Director of Virtual Reality & Immersive Techology (VR-IT) Clinic and Lab.
    Use of technology to understand the interaction of sensation, embodiment, and emotional/ behavioral regulation.
    Virtual reality treatments as a sensory modulating device to treat disorders involving body image, sensation, and control. Exploration of the use of mirrored visual feedback while inhabiting a virtual avatar to treat pain and somatic symptom related disorders.

  • Regina Casper

    Regina Casper

    Professor of Psychiatry and Behavioral Sciences, Emerita

    Current Research and Scholarly Interests Alterations in brain morphology and organization during starvation and anorexia nervosa

  • Erin Cassidy Eagle

    Erin Cassidy Eagle

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Erin Cassidy-Eagle specializes in the treatment of mental health disorders in adults and older adults. She has practiced as a Clinical Psychologist for more than 20 years. Dr. Cassidy-Eagle has a special interest in sleep, cognition and mental health of older adults.

  • Anusha Chandrakanthan

    Anusha Chandrakanthan

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Anusha Chandrakanthan is a clinical instructor in psychiatry. She is a family practice physician who is board certified in Addiction Medicine. Previously, she was the medical director for a company that provided substance use treatment using telemedicine. Presently, she works with the Valley Homeless Healthcare Program at Santa Clara Valley Medical Center providing services to a marginalized population. She also continues to teach at the Stanford Addiction Medicine fellowship.

  • Sripriya Chari

    Sripriya Chari

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Sripriya (Priya) Chari is a CA Licensed Clinical Psychologist and Clinical Assistant Professor working with the INSPIRE Clinic at Stanford. Dr. Chari's clinical interests lie in early identification of the psychosis risk syndrome and providing evidence based psychotherapeutic interventions from a recovery oriented perspective. Prior to the INSPIRE Clinic, Dr. Chari was a clinical assessor for the North American Prodrome Longitudinal Study, aimed at studying the predictors for conversion to psychosis of youth at clinical high risk for psychosis. She also worked for Santa Clara County Department of Mental Health, in inpatient, outpatient, and forensic settings providing psychotherapy and assessment services.

  • Octavio Choi, MD, PhD

    Octavio Choi, MD, PhD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Choi is a forensic psychiatrist and clinical associate professor of psychiatry. He holds an MD in psychiatry and a PhD in neuroscience. As Training Director in the Program in Psychiatry and the Law, he is helping establish the first forensic psychiatry fellowship program at the Stanford School of Medicine. In addition, he provides consultation services for interventional psychiatrists and therapists as well as for attorneys and the court system.

    As a forensic psychiatrist, Dr. Choi specializes in neurolaw, an emerging interdisciplinary field that studies the use and misuse of neuroscience-based evidence in the courtroom. His research interests include the use of functional brain imaging to discern mental states (e.g. lie detection, pain assessment), and the neural basis for moral decision making (e.g. defects in moral reasoning brain centers giving rise to psychopathy). A central question he considers is: how do advances in our knowledge of the neural basis of behavior change perceptions of how offenders should be punished? He has testified as a court-appointed expert, as well as for the prosecution and defense, in many high-profile and complex cases involving psychiatric, neurologic, medical, and medication-related legal claims.

    Dr. Choi?s clinical interests include neuromodulatory approaches to treat psychiatric illness, such as the use of transcranial magnetic stimulation (TMS) to treat major depression. He is part of the interventional psychiatry group of Stanford Medicine, conducting clinical work and research to advance the power, precision, and scope of neuromodulation.

    Dr. Choi is an experienced public speaker, and has given a number of talks to lay and professional audiences on neurolaw, the neuroscience of psychopathy, and the neuroscience of moral decision-making. He is a featured TEDx speaker on the topic "Can Neuroscience Eradicate Psychopathy?"

  • Mehak Chopra

    Mehak Chopra

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Her expertise lies in treating special populations such as athletes and students. She has also had training in dealing with cultural psychiatry issues. She has been trained to treat students with a variety of mental health issues ? ADHD, Bipolar disorder, schizophrenia, eating disorders, insomnia, mood disorder and personality disorders.

  • Kate Corcoran, PhD

    Kate Corcoran, PhD

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Corcoran is a Clinical Professor in the Department of Psychiatry and Behavioral Sciences. She is actively involved in teaching psychotherapy to graduate students, psychiatry residents, and postdoctoral fellows. She is the Training Director for the Clinical Psychology Postdoctoral Fellowship program and the Curriculum Director of CBT Training for the Psychiatry Residency program. In her clinical practice, Dr. Corcoran specializes in cognitive-behavioral therapy (CBT) and mindfulness-based interventions for adults experiencing anxiety, stress, and depression.

  • Francesco Nandkumar Dandekar

    Francesco Nandkumar Dandekar

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Dandekar is the Associate Director of Sports Psychiatry and a Clinical Assistant Professor at Stanford University. After graduating summa cum laude from the University of Southern California with a B.S. in Biomedical Engineering, he earned a Regent's Scholarship to complete his M.D. at UC San Diego, where he received the American Academy of Neurology?s Prize for Excellence. During his residency and fellowship at Stanford, Dr. Dandekar focused on providing care to elite athletes and students utilizing a combination of lifestyle changes (sleep, nutrition, recovery), medication management, and psychotherapy. Teamed with Dr. Noordsy, he helped to incorporate psychiatric services into Stanford's sports psychology program, and continues to see elite athletes as part of the Sports Psychiatry clinic. He is an avid tennis fan and enjoys training and competing in leagues and tournaments.

  • Beth Darnall

    Beth Darnall

    Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Psychiatry and Behavioral Sciences (General Psychiatry & Psychology (Adult)) at the Stanford University Medical Center

    Current Research and Scholarly Interests The Stanford Pain Relief Innovations Lab is dedicated to better characterizing and treating pain. My specific interests: (1) expand and scale access to behavioral medicine for acute and chronic pain via digital and brief treatments; (2) reduce need for opioids and associated risks; (3) reduce pain and its negative impacts via behavioral medicine; (4) train physicians and care providers on behavioral pain medicine principles and therapeutic engagement to enhance patient outcomes.

  • Smita Das

    Smita Das

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Smita Das, MD, PhD, MPH is Board Certified in Psychiatry, Addiction Psychiatry and Addiction Medicine. Dr. Das studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. She completed psychiatry residency and was chief resident at Stanford followed by an addiction psychiatry fellowship at UCSF. She has 20 years of experience in research in healthcare quality and addiction. Dr. Das has an appointment to the APA Addiction Council. She has been a leader in the Northern California Psychiatric Society since 2012 and is now President of the APA District Branch. Prior to her position as Medical Director of Psychiatry at Lyra Health, Dr. Das was Director of Addiction Treatment Services at the Palo Alto VA. In addition to her work at Lyra, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Assistant Professor.

  • Sallie De Golia

    Sallie De Golia

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. De Golia specializes in the treatment of mood and anxiety disorders with an expertise in time-limited dynamic psychotherapy. She is Section Chief of the Assessment Clinics and Director of the Evaluation Clinic. Dr. De Golia is the Associate Chair for Clinician Educator Professional Development where she is involved in developing faculty development programs including mentorship. She is also the Associate Residency Director of the Adult Psychiatry Residency Program where she has been involved in educational programming and curricular development. She is a Peer Teaching Coach in the Stanford Teaching and Mentoring Academy, teaches regularly with the Stanford Center for Faculty Development, and is a Senior Fellow at Stanford's Center for Innovation in Global Health. She currently serves on the Executive Committee of the American Association of Directors of Psychiatry Residency Training.

  • Charles DeBattista

    Charles DeBattista

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult) at the Stanford University Medical Center

    Current Research and Scholarly Interests Treatment resistant depression.

    Novel biological interventions in the treatment of mental illness.

    Anti-glucocorticoid drugs in the treatment of mood disorders.

    Augmentation strategies in the treatment of depression.

  • Huiqiong Deng, MD, PhD

    Huiqiong Deng, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Huiqiong Deng is a clinical assistant professor of psychiatry. In addition to a medical degree, she earned a PhD, with a major in rehabilitation science and a minor in neuroscience. Specializing in the treatment of alcohol/substance addiction, interventional and cultural psychiatry, her goal is to help each patient along the journey to achieve optimal health and quality of life.

    As the co-author of more than a dozen scholarly articles, Dr. Deng?s work has appeared in Psychiatry Research, Journal of Studies on Alcohol and Drugs, American Journal on Addictions, Brain Stimulation, and other publications.

    Dr. Deng has won numerous honors and awards such as the National Institute on Drug Abuse Young Investigator Travel Award, the Ruth Fox Scholarship from the American Society of Addiction Medicine, and College on the Problems of Drug Dependence Travel Award for Early Career Investigators. In addition, she was selected to attend the Annual American Psychiatry Association Research Colloquium for Junior Investigators. Since she joined faculty at Stanford, Dr. Deng has received research grant support by the Department of Psychiatry and Behavioral Sciences Innovator Grant Program.

  • Jennifer Douglas

    Jennifer Douglas

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Jen Douglas specializes in the management of anxiety, disordered eating, and trauma. She maintains a practice of conducting psychotherapy, teaching, and supervision from an intersectional lens. Dr. Douglas currently serves patients through the Eating Disorders, THRIVE, and DBT Clinics at Stanford School of Medicine.

  • Katherine Eisen

    Katherine Eisen

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Eisen is a Clinical Assistant Professor and CA Licensed Clinical Psychologist working with the INSPIRE Clinic at Stanford. Her research and clinical interest center on therapeutic interventions that support recovery for individuals living with serious mental illness, in particular for individuals with psychosis. Dr. Eisen received her bachelor?s degree from Cornell University, and her PhD from the University of Connecticut, and completed postdoctoral training at Stanford University. Before coming to the INSPIRE Clinic, Dr. Eisen worked for over 10 years as a psychologist on the acute inpatient units at Stanford Health Care. Dr. Eisen is trained in CBT for psychosis (CBTp) and has worked with colleagues to train therapists, nursing and multidisciplinary staff, medical students, and residents to integrate CBTp informed, recovery-oriented approaches into their work with individuals with psychosis. She provides both individual and group-based cognitive behavioral therapy.

  • Neir Eshel, MD, PhD

    Neir Eshel, MD, PhD

    Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Eshel (he/him/his) is a psychiatrist and instructor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.

    His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the new Stanford LGBTQ+ program.

    His research interests include the use of optogenetic, electrophysiological, neuroimaging, and behavioral approaches to probe the neural circuits of reward processing, decision making, and social behavior. He recently won a multi-year grant from the National Institute of Mental Health to study the neural circuits of frustration and aggression.

    Dr. Eshel has published articles on topics such as the role of dopamine in learning, the neuroscience of irritability, LGBTQ health, reward and punishment processing in depression, behavioral predictors of substance use among adolescents, and the mechanism of transcranial magnetic stimulation. His work has appeared in Nature, Science, Nature Neuroscience, Annual Review of Neuroscience, JAMA, JAMA Psychiatry, Neuropsychopharmacology, Proceedings of the National Academy of Sciences, and Journal of Neuroscience. He is also the author of the book Learning: The Science Inside, a publication of the American Association for the Advancement of Science.

    He has delivered presentations on anger expression in patients with PTSD, the neural circuitry of learning, dopamine prediction errors, and LGBTQ-related topics at meetings of the American College of Neuropsychopharmacology, Society of Biological Psychiatry, and Association of American Medical Colleges, among others. He is also an associate editor of the Journal of Gay and Lesbian Mental Health, and an ad-hoc reviewer for numerous publications including Science, JAMA Psychiatry, Biological Psychiatry, and Current Biology.


    Dr. Eshel has won honors for his scholarship and advocacy, including the Marshall Scholarship, the Outstanding Resident Award from the National Institute of Mental Health, the Science and SciLifeLab Grand Prize for Young Scientists, and the National LGBT Health Achievement Award.

    He is a member of the American Psychiatric Association, Society of Biological Psychiatry, Association of Gay & Lesbian Psychiatrists, Society for Neuroscience, and other professional associations. He is also an advocate for LGBTQ rights, recently serving as the LGBTQ Chair of the Stanford Graduate Medical Education Diversity Committee.

    Prior to Stanford, Dr. Eshel trained and conducted research at the National Institutes of Health, Princeton University, the World Health Organization, University College London, and Harvard University.

  • Stephanie Allen Evans

    Stephanie Allen Evans

    Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Resume visible at http://bit.ly/EvansResume
    This link needs to be copied and pasted into your browser to view.

  • Lief Ericsson Fenno

    Lief Ericsson Fenno

    Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Fenno is a psychiatrist and Instructor at Stanford University School of Medicine.

    Leveraging his strengths in neuroscience research and bioengineering, his goal is to design, construct, validate, and apply novel molecular and viral tools to understand the brain in health and disease for the benefit of diverse patient populations. His clinical interests include the treatment of substance use disorders and co-occurring mood disorders.

    His specific research interests include the development and application of novel optogenetic tools that combine genetically encoded molecules and light to modulate neurons. Dr. Fenno directs a team focused on expanding the use of novel, intersectional viral targeting approaches, with the objective of precisely establishing links between neuron circuitry and behavior. He has patented advances for optically controlled CNS dysfunction and social dysfunction.

    Dr. Fenno has co-written articles on optogenetic tools and other topics in the journals Annual Review of Neuroscience, Neurobiology of Mental Illness, Molecular Psychiatry, Current Protocols in Neuroscience, Nature, and Cell. He is also the co-author of articles on neural mechanisms of autism spectrum disorder, which have appeared in Science Translational Medicine and Nature.

    Dr. Fenno has delivered presentations worldwide at events including the meeting of the National Science Foundation NeuroNex Program of Next Generation Networks for Neuroscience. He also has been an invited speaker at the Robarts Research Institute, a Canada-based facility accelerating medical discovery of treatments for some of the most debilitating diseases of our time, and the Gordon Research Conference on Molecular Pharmacology, an international forum for the presentation of pre-publication frontier research.

    For his scholarship and teaching achievements, Dr. Fenno has won numerous honors. They include the Laughlin Fellowship from the American College of Psychiatrists, which honors individuals deemed likely to make a significant contribution to the field of psychiatry, and the Humanism and Excellence in Teaching Award from the Arnold P. Gold Foundation, which honors exceptional teaching skills and commitment to the compassionate treatment of patients and families, students, and colleagues.

    Dr. Fenno is a member of the Society for Neuroscience, The American Medical Association, and the American Society of Addiction Medicine.

  • Katie Fracalanza

    Katie Fracalanza

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Dr. Fracalanza is interested in factors underlying the development and maintenance of mood and anxiety disorders. She has conducted research on cognitive factors thought to maintain anxiety, such as intolerance of uncertainty and perfectionism. She is interested in the patient perspective, and conducting research from a qualitative lens to better understand this.

  • Elise Gibbs

    Elise Gibbs

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Elise Gibbs is a licensed psychologist who provides cognitive behavioral therapy for individuals with eating, mood, and anxiety disorders. She received her doctorate in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium and her BA with Honors and Distinction in Psychology from Stanford University. She completed her clinical internship at the Vanderbilt University Medical Center - VA Internship Consortium and her postdoctoral fellowship at Stanford University?s School of Medicine.

  • Nancy A. Haug

    Nancy A. Haug

    Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Nancy A. Haug, Ph.D. is Adjunct Clinical Associate Professor and Addiction Medicine Fellowship Program Faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and supervises a supplemental practicum for doctoral students who are co-facilitating group therapy.

    Dr. Haug is also Professor and Associate Chair of the Department of Psychology at Palo Alto University where she teaches, advises and supervises graduate students, and leads the Harm Reduction and Addiction Treatment Research Laboratory. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program.

    Dr. Haug was recently funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. She is active in the Society of Addiction Psychology (American Psychological Association, Division 50) and chairs the Outreach and Dissemination committee. Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. Throughout her academic career, Dr. Haug has focused on behavioral and psychosocial interventions for treating addiction, and currently has projects studying mindfulness group treatment for addiction, cannabis vaping practices and online interventions for alcohol harm reduction. Dr. Haug has been licensed in CA since 2004 and has a private practice which informs her research and teaching.

  • Chris Hayward

    Chris Hayward

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Hayward's research has focused on risk factors for the onset of adolescent internalizing disorders in adolescent girls and the role of early puberty specifically.

  • Kimberly Hill

    Kimberly Hill

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Hill received her Ph.D. in Clinical Psychology from Ohio University. She completed her predoctoral internship at the Veterans Affairs Palo Alto Health Care System and postdoctoral fellowship in the Psychiatry Department at the Stanford University School of Medicine where she currently serves as a Clinical Professor. Dr. Hill has published articles and made presentations related to psychology training, pain management, serious mental illness including Post Traumatic Stress Disorder, and sexual dysfunction.

    Dr. Hill's time is divided across clinical, research, administrative, and teaching domains. Her current clinical interests are varied including anxiety, mood disorders, relationship difficulties, and post-traumatic stress disorder. The bulk of her time is committed to psychology training as the Director of Clinical Training for the PGSP-Stanford Psy.D. Consortium. On a national level, she currently serves as a Board Member of the Association of Psychology Postdoctoral and Internship Centers (APPIC).

  • Janie J. Hong, Ph.D.

    Janie J. Hong, Ph.D.

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Hong is a Clinical Associate Professor in the Department of Psychiatry & Behavioral Sciences and psychologist in the Adult Neurodevelopment Clinic. She is invested in developing evidence-based ways to individualize care and address diversity factors in therapy. She has published and presented widely on these and other topics in psychology.

    In clinical practice, she specializes in providing cognitive behavior therapy (CBT) and other evidence based treatments. She is also committed to helping neurodiverse and culturally diverse individuals work with their differences, navigate prevailing social norms, and advocate for their needs as diverse individuals.

  • Valerie Hoover

    Valerie Hoover

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Dr. Hoover's research interests include translating behavioral weight management interventions to the Cardiology setting, and developing novel interventions to improve biopsychosocial outcomes in Cardiology.

  • Rona Hu

    Rona Hu

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Hu is Medical Director of the Acute Psychiatric Inpatient Unit at Stanford Hospital, specializing in the care of those with serious mental illnesses, including schizophrenia, bipolar and depression. She completed medical school and residency in psychiatry at the University of California, San Francisco, and fellowships in Pharmacology and Schizophrenia Research through the National Institutes of Health. She is also active in the minority issues and cultural psychiatry, and has received regional and national recognition for her clinical care, research and teaching.

  • Agnieszka Kalinowski

    Agnieszka Kalinowski

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio I am a translational physician-scientist focused on studying the role of the immune system in patients with schizophrenia. My work spans careful clinical characterization of patients to understanding mechanisms in basic science model systems, allowing to provide mechanistic understanding to observations in clinical samples. Currently, I'm focused on deciphering the role of the complement system and how the known genetic risk translates into pathophysiological disease mechanisms. I hope that this work will pave the way to novel treatment strategies.

  • Katherine Kaplan

    Katherine Kaplan

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Dr. Kaplan's research interests span four (often overlapping) domains: (1) pathophysiologic aspects of insomnia and hypersomnia in mood disorders, including mechanisms, correlates, and sequelae of these sleep disturbances; (2) behavioral interventions for sleep disturbances in adults and adolescents; (3) circadian and psychosocial factors impacting sleep in adolescence; and (4) machine learning approaches to big data.

  • Laura B. Kasper, PhD

    Laura B. Kasper, PhD

    Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio I am psychologist and have been practicing psychotherapy for over 18 years. I have experience working with a diverse group of clients with respect to presenting concerns, gender, sexual orientation, and race/ethnicity.

    Regardless of their background, the majority of my clients are highly intelligent and accomplished people who are interested in taking their personal and professional relationships to the next level, starting with themselves. My therapeutic approach blends my first-hand experience of the high-performing professional workplace with buddhist psychology and tools to offer support that is unrelentingly compassionate, direct, and powerful.

    I have particular research and clinical expertise in authenticity with one's self and in relationships, interpersonal communication, and issues of sexual orientation, gender, and sexuality. My services include individual, couples, and group psychotherapy. I also do video counseling sessions with individuals and couples in CA, DC and VA, the places where I am licensed.

    I earned my master?s and doctoral degrees from the University of Maryland?s Counseling Psychology program. I completed my internship and post-doctoral training, and was a Staff Psychologist at the The George Washington University Counseling Center for several years before starting my private practice. I am currently in the Interpersonal Dynamics Facilitator Training Program at Stanford University in the Graduate School of Business to become a small group facilitator for their popular elective, Interpersonal Dynamics.

    I have been practicing Vipassana meditation for over fifteen years. I?ve spent eighty-five days on silent meditation retreats in that time, and have a mindfulness orientation to my work.

    I am a member of the American Group Psychotherapy Association and the Northern California Group Psychotherapy Society, and the Northern California Society for Psychoanalytic Psychology. I am licensed and insured in California (PSY28532), Washington D.C. (PSY1000362) and Virginia (PSY0810004715).

  • Jennifer Keller

    Jennifer Keller

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests interpersonal violence and abuse prevention; empowerment of women; cognitive and affective information processing in depression; clinical, biological, and neuropsychological aspects of depression; South Asian mental health

  • Terence Ketter

    Terence Ketter

    Professor of Psychiatry and Behavioral Sciences (Psychopharmacology), Emeritus

    Current Research and Scholarly Interests The use of brain imaging methods for understanding the neurobiology of mood disorders and to target treatments for patients with bipolar disorders. Research in the use of novel medications and combinations of medications in the treatment of bipolar disorders. Research on the development and course of bipolar disorder in late adolescence and young adulthood, particularly in college students, and links between creativity, temperament, and mood disorders.

  • Jessie Kittle

    Jessie Kittle

    Clinical Assistant Professor, Medicine

    Current Research and Scholarly Interests Hypnosis for perioperative symptom management in elective orthopedic surgery.

  • Ian H. Kratter, MD, PhD

    Ian H. Kratter, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Kratter is a fellowship-trained psychiatrist and clinical assistant professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He is also director of Invasive Technologies in the Stanford Brain Stimulation Laboratory.

    His clinical interests include depression, obsessive-compulsive disorder, eating disorders, sleep disorders, adult autism spectrum disorder, Huntington?s disease, and neuropsychiatric predictors of outcomes following deep brain stimulation for Parkinson?s disease.

    His research interests include deep brain stimulation and neuroimaging. He is a co-investigator of a study of deep brain stimulation for obsessive-compulsive disorder. He is also a co-investigator of a study exploring the use of individualized neuroimaging biomarkers to predict OCD patients? response to repetitive transcranial magnetic stimulation (rTMS). This therapy is a noninvasive form of brain stimulation that uses a magnet to stimulate targeted areas of the brain. Both studies are supported by the Foundation for OCD Research

    Dr. Kratter has published articles on topics such as deep brain stimulation for Parkinson?s disease and gene-targeting therapy for Huntington disease. His work has appeared in the Journal of Clinical Investigation, Proceedings of the National Academy of Science, and American Journal of Human Genetics. He also co-authored the chapter on major depression in the textbook Deep Brain Stimulation: Techniques and Practice.

    Dr. Kratter has presented his work at the annual meetings of the American Neuropsychiatric Association, Hereditary Disease Foundation, and Society for Neuroscience. Topics include cognitive changes following deep brain stimulation for Parkinson?s disease, antipsychotic-induced thrombocytopenia, and mediators of pathology in Huntington?s disease.

    For his scholarship and research achievements, Dr. Kratter has won numerous honors. They include the Miller Foundation Award for Psychiatric Research. He also won the Ruth L. Kirschstein National Research Service Award from the National Institute of Neurological Disorders and Stroke.

    He is or has been a member of the American Neuropsychiatric Association, American Society of Clinical Psychopharmacology, American Association for Geriatric Psychiatry, Academy of Psychosomatic Medicine, and Society for Neuroscience.

  • Sheila Lahijani

    Sheila Lahijani

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio After graduating from Brown Medical School, Dr. Lahijani completed the Combined Internal Medicine/Psychiatry Residency Program at Rush University Medical Center in Chicago. She then served as a physician in the areas of primary care and triple diagnosis (addiction, HIV, mental health).

    Thereafter, Dr. Lahijani completed the Psychosomatic Medicine Fellowship at the Feinberg School of Medicine of Northwestern University where she worked at the Lurie Comprehensive Cancer Center. During her fellowship, she also served as a psycho-oncologist at Memorial Sloan Kettering Cancer Center. Dr. Lahijani is trained in and administers different psychotherapeutic modalities, including Meaning Centered Psychotherapy and Dignity Therapy.

    Dr. Lahijani joined the faculty of Stanford University School of Medicine in 2015 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since her initial appointment, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center where she has provided psychiatric consultation services to patients with cancer and collaborated closely with her hematology and oncology colleagues to deliver comprehensive cancer care.

    In 2019, she was appointed as the Medical Director of the Stanford Cancer Center Psychosocial Oncology Program where she works in Stanford Cancer Center leadership and oversees the development and operationalization of psychiatric consultation for patients with cancer. Dr. Lahijani also attends on the inpatient Consultation Liaison Psychiatry Service at Stanford Hospital and Clinics to provide care for all patients with complex medical and psychiatric diagnoses and to teach psychiatry, internal medicine, and neurology trainees.

    As Faculty of the Advancing Communication Excellence at Stanford, Dr. Lahijani leads foundational workshops for faculty and staff to advance communication skills with patients, families, and their colleagues. She is committed to developing and contributing to efforts that focus on relationship centered skills and provider wellness.

    Her clinical and scholarly interests include the interface of Medicine and Psychiatry, Psycho-Oncology, psychopharmacology, collaborative care models, psychotherapy for the medically ill, interdisciplinary medical education, teaching, and academic writing.

  • Laura C. Lazzeroni, Ph.D.

    Laura C. Lazzeroni, Ph.D.

    Professor (Research) of Psychiatry and Behavioral Sciences and of Biomedical Data Science

    Current Research and Scholarly Interests Statistics/Data Science. I develop & apply models, methods & algorithms for complex data in medical science & biology. I am also interested in the interplay between fundamental statistical properties (e.g. variability, bias, p-values) & how scientists actually use & interpret data. My work in statistical genetics includes: the invention of Plaid bi-clustering for gene expression data; methods for twin, association, & family studies; multiple testing & estimation for high dimensional arrays.

  • Anna Lembke, MD

    Anna Lembke, MD

    Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center

    Bio Dr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Associate Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. She is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine.

    Dr. Lembke was one of the first in the medical community to sound the alarm regarding opioid overprescribing and the opioid epidemic. In 2016, she published her best-selling book on the prescription drug epidemic, "Drug Dealer, MD ? How Doctors Were Duped, Patients Got Hooked, and Why It?s So Hard to Stop" (Johns Hopkins University Press, 2016). Her book was highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).

    "Drug Dealer, MD" combines case studies with public policy, cultural anthropology, and neuroscience, to explore the complex relationship between doctors and patients around prescribing controlled drugs. It has had an impact on policy makers and legislators across the nation. Dr. Lembke has testified before Congress and consulted with governors and senators from Kentucky to Missouri to Nevada. She was a featured guest on Fresh Air with Terry Gross, MSNBC with Chris Hayes, and numerous other media broadcasts.

    Using her public platform and her faculty position at Stanford University School of Medicine, Dr. Lembke has developed multiple teaching programs on addiction and safe prescribing, as well as opioid tapering. She has held multiple leadership and mentorship positions and received the Stanford?s Chairman?s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. Dr. Lembke continues to educate policymakers and the public about causes of and solutions for the problem of addiction.

    Look for her new book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021).

  • Stacy Lin

    Stacy Lin

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Stacy Lin is a licensed psychologist in the Department of Psychiatry and Behavioral Sciences who provides culturally-informed psychotherapy for the treatment of emotion dysregulation, eating disorders, and trauma. Dr. Lin has specialized training in comprehensive Dialectical Behavior Therapy and Cognitive Behavioral Therapy. She is broadly interested in issues of diversity and inclusion in clinical, training, and professional settings. Her research has examined cultural factors affecting disordered eating and body image in racial/ethnic minorities.

  • Anne Juliana Lockman

    Anne Juliana Lockman

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Juliana Lockman is Clinical Assistant Professor in the Neuropsychiatry Division in Department of Psychiatry & Behavioral Sciences at Stanford. She is also appointed to La Selva Group, where she directs the Functional Neurologic Symptom Disorder (FND) Track within their state-of-the-art residential, partial hospitalization and intensive outpatient programs. She completed residencies in both Neurology at the University of Virginia and Psychiatry at Stanford Hospital & Clinics. Her clinical activities include providing pharmacologic and behavioral care for clients with psychiatric and behavioral conditions in the context of neurological illness, including epilepsy, stroke, movement disorders and others. She also teaches and supervises Stanford residents and fellows in Neuropsychiatry. Professional goals include advancement of research and clinical care and improving access for clients suffering from neuropsychiatric conditions, including FND and related disorders.

  • Kristine Luce

    Kristine Luce

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Luce is a Psychologist and Clinical Associate Professor in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. She received her doctorate in Clinical Psychology from Kent State University. She completed a pre-doctoral internship at the Seattle Veterans Hospital and a post-doctoral research fellowship at Stanford University in the Department of Psychiatry and Behavioral Sciences. Dr. Luce has specialized clinical and research experience with eating-related disorders and is the Co-Director of the Stanford Adult Eating and Weight Disorders Clinic. In addition, Dr. Luce treats anxiety and mood disorders and has specialized clinical training in Cognitive Behavioral Therapy and Dialectical Behavioral Therapy.

  • Maryam S. Makowski, PhD, FACN

    Maryam S. Makowski, PhD, FACN

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Maryam S. Makowski, PhD, FACN is a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences. Dr. Makowski is a Certified Lifestyle, Health and Wellness Coach. The focus of her current work is reducing fatigue and improving mood and cognitive performance of professionals with high cognitive demands. As a member of Stanford Medicine WellMD & WellPhD Center team, Dr. Makowski leads initiatives at that promote personal well-being, self-care and culture of wellness among clinicians at Stanford Medicine.

    Dr. Makowski is a Fellow of the American College of Nutrition, a member of the Academy of Nutrition and Dietetics, American and Canadian Nutrition Societies, and American Nutrition Association. She completed her masters and doctoral studies in clinical nutrition, nutritional epidemiology and medical science at University of Toronto in Canada. Over the course of her career, she has authored many highly cited scientific papers on nutrition and clinician well-being.

  • Jose R. Maldonado, MD, FAPM

    Jose R. Maldonado, MD, FAPM

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) and, by courtesy, of Emergency Medicine and of Medicine at the Stanford University Medical Center and, by courtesy, of Law

    Current Research and Scholarly Interests Pathophysiology and Management of Delirium, Acute Brain Failure and Cognitive Impairment, Neuropsychiatric Sequelae of Traumatic Brain Injury, Factitious Disorder & Munchausen's Syndrome, Cultural Diversity in Medical Care, Psychiatric Complications of Bone Marrow Transplantation, Conversion Disorder, Depression in the Medically Ill, Neuropsychiatric Sequelae of Chronic Fatigue Syndrome.

  • Rachel Manber, PhD

    Rachel Manber, PhD

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center

    Current Research and Scholarly Interests 1) Insomnia during pregnancy
    2) Acupuncture for chronic low back pain

  • Johnna Medina

    Johnna Medina

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Johnna Medina, PhD, is a Clinical Instructor at Stanford medicine in the Department of Psychiatry and Behavioral Sciences, where she is an attending psychologist in the Addiction Medicine/Dual-Diagnosis Clinic and continues to collaborate on research projects evaluating mind-body interrelationships (e.g., stress and health) and interventions (e.g., hypnosis, yoga). Dr. Medina earned her bachelor's degrees in Psychology and Art Practice at Stanford University (2009) and her PhD in Clinical Psychology at UT Austin (2017). Her dissertation research focused on exercise and yoga-based interventions for targeting anxiety-related risk and maintenance factors underlying addictive behaviors. She returned to Stanford to complete her postdoctoral research fellowship (2017-2019) as a T32 scholar working under Dr. David Spiegel in the Center on Stress and Health Lab.

Footer Links:

Stanford Medicine Resources: